Pfizer's Zeldox Receives Approval in Europe to Treat Manic or Mixed Episodes Associated With Bipolar Disorder.
Publication: PR Newswire
Publication Date: 31-OCT-05
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
NEW YORK, Oct. 31 /PRNewswire/ -- Pfizer Inc said today that its atypical antipsychotic Zeldox(R) (ziprasidone HCl) received approval in 11 European Union member states and two EU observer countries for the treatment of manic or mixed episodes of moderate severity in bipolar disorder. Zeldox is currently approved in the 11 European member states as a treatment for schizophrenia. Ziprasidone is marketed as Geodon(R) in the...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
